Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats

Molecular and Cellular Biochemistry

Volumn 247, Issue 1-2, 2003, Pages 163-169

  Ebenezar, Kesavarao Kumar ^a   Sathish, Venkatachalem ^a   Devaki, Thiruvengadam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Isoproterenol; L arginine; L lysine; Lysosomal hydrolases; Membrane bound phosphatases; Myocardial infarction

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ARGININE; BIOCHEMICAL MARKER; ISOPRENALINE; LYSINE; LYSOSOME ENZYME; MEMBRANE ENZYME; PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME ACTIVITY; HEART INFARCTION; HEART INJURY; HEART PROTECTION; HISTOPATHOLOGY; INFLAMMATION; MALE; NONHUMAN; RAT; REVIEW;

ANIMALS; ARGININE; CELL MEMBRANE; DISEASE MODELS, ANIMAL; HYDROLASES; ISOPROTERENOL; LYSINE; LYSOSOMES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHORIC MONOESTER HYDROLASES; RATS; RATS, WISTAR; REFERENCE VALUES;

ANIMALIA;

EID: 0038419529     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024115714236     Document Type: Review

References (47)

1. Sushamakumari S, Jayadeep A, Suresh Kumar HS, Menon VP: Effect of carnitine on malondialdehyde, taurine and glutathione levels in heart of rats subjected to myocardial stress by isoproterenol. Ind J Exp Biol 27: 134-137, 1989
2. Todd GL, Cullan GE, Cullan GM: Isoproterenol induced myocardial necrosis and membrane permeability alterations in the isolated perfused rabbit heart. Exp Mol Pathol 33: 43-54, 1980
3. Manjula TS, Devi CS: Effect of aspirin on isoproterenol induced changes in lipid metabolism in rats. Ind J Med Res 98: 30-33, 1993
4. Chappel CI, Rona G, Balasz T, Gaudry R: Severe myocardial necrosis produced by isoproterenol in the rat. Arch Int Pharmacodyn Ther 122: 123-128, 1959
5. Davies MJ: The pathology of myocardial ischaemia. J Clin Pathol 30: 45-52, 1977
6. Egashira K, Hirooka Y, Kuga T, Mohri M, Takishita A: Effect of L-arginine supplementation on endothelium dependent coronary vasodilation in patients with angina pectoris and normal coronary arterio grams. Circulation 94: 130-134, 1996
7. Zhu BQ, Sun YP, Sievers RS, Shuman JL, Chatterjee K, Parmley WW, Wolfe CL: L-arginine decreases infarct size in rats exposed to environmental tobacco Smoke. Am Heart J 132: 91-100, 1996
8. Marchesi S, Lupateli G, Siepi D, Roscini AR, Vaudo G, Sinzinger H, Mannarino E: Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males. J Clin Pharm Ther 26: 343-349, 2001
9. West ES, Todd WR, Mason HS, Van Bruggen JT: In: Test Book of Biochemistry, 4th edn. Oxford and IBH Publishing Company Pvt. Ltd., 1996, pp 1143-1263
10. Egan JM, Henderson TE, Bernier M: Arginine enhances glycogen synthesis in response to insulin in 3T3-L1 adipocytes. Am J Physiol 265: E61-E66, 1995
11. Smulders RA, Aarsen M, Teerlink T, De Vries PM, Van Kamp GJ, Donker AJ, Stehouwer CD: Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginine induced vasodilation causes to be explained by non-specific effects of cationic aminoacids. Clin Sci (Colch) 92: 367-374, 1997
12. Kato T, Sano M, Mizutani N: Inhibitory effect of intravenous lysine infusion on urea cycle metabolism. Eur J Pediatr 146: 56-58, 1987
13. Allman KG, Stoddart AP, Young JD: Effect of L-lysine on nitric oxide production in ovine endotoxaemia. Br J Anasth 81: 188-192, 1998
14. Sathish V, Vimal V, Ebenezar KK, Devaki T: Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol-induced myocardial infarction in rats. J Pharm Pharmacol 54: 133-137, 2002
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with Folin-phenol reagent. J Biol Chem 193: 265-275, 1951
16. King J: The dehydrogenase of oxido reductase - Lactate dehydrogenase. In: D. Van (ed). Practical Clinical Enzymology. Nostrand Co., London, 1965, pp 83-93
17. Okinaka S, Kumogai H, Ebashi S, Sugita H, Momoi H, Toyokura Y, Fujie Y: Serum creatine phosphokinase activity in progressive muscular dystrophy and neuro muscular diseases. Arch Neurol 4: 520-525, 1961
18. Bergmeyer HU, Bernt E: Aminotransferases and related enzymes. In: H.U. Bergmeyer (ed). Methods of Enzymatic Analysis, Vol. 2,2nd edn. Academic Press, New York, 1974, pp 735-763
19. Bonting SL: In: T.M. Dembroski, T.H. Schmidt, G. Blumchen (eds). Membrane and Ion Transport. Biobehavioural Base of Coronary Heart Disease, Vol. 1. Wiley, Interscience, London, 1970, p 257
20. Hjerten S, Pan H: Purification and characterization of two forms of low affinity calcium ion-ATPase from erythrocyte membranes. Biochim Biophys Acta 728: 281-288, 1983
21. +-ATPase activities in normal regenerating and malignant cells. Biochim Biophys Acta 684: 67-74, 1982
22. Wattiaux R: In: G.A. Jamieson, D.M. Robinson (eds). Mammalian Cell Membranes, 2nd edn. Butterworth, London, 1977, p 165
23. Kawai Y, Anno K: Mucopolysaccharide degrading enzymes from the liver of the squidommastrephes solanipacificus. Biochim Biophys Acta 242: 428-436, 1971
24. Conchie J, Gelman AL, Levry GA: Inhibition of glycosidase by aldonolactones of corresponding configuration. Biochem J 103: 609, 1967
25. Moore JC, Morris JE: A simple automated colorimetric method for determination of N-acetyl-β-D-glucosaminidase. Ann Clin Biochem 19: 157-159, 1982
26. King J: The hydrolases-acid and alkaline phosphatases. In: D. Van (ed). Practical Clinical Enzymology. Nostrand Co., London, 1965, pp 191-208
27. Sapolsky AI, Altman RD, Howell DS: Cathepsin D activity in normal and osteoarthritic human cartilage. Fed Proc 32: 1489-1493, 1973
28. Wexler BC, Kittinger GN: Myocardial necrosis in rats: Serum enzymes, adrenol steroids and histopathological alternations. Circ Res 13: 159-171, 1963
29. Norikoff AB: Lysosomes and related particles. In: J. Branchet, E. Mistry (eds). The Cell. Academic Press, New York, 1961, p 423
30. Sreepriya M, Saravanan N, Devaki T, Nayeem M: Protective effects of L-arginine in experimental myocardial injury induced by β-adrenergic stimulation in rats. J Clin Biochem Nutr 27: 19-26, 1999
31. Ravichandran LV, Puvanakrishnan R, Thomas JK: Alternations in heart lysosomal stability in isoproterenol-induced myocardial infarction in rats. Biochem Int 22: 387-396, 1990
32. Ravichandran LV, Puvanakrishnan R, Thomas Joseph K: Influence of isoproterenol induced myocardial infarction on certain glycohydrolase and cathepsins in rats. Biochem Med Metab Biol 45: 6-15, 1991
33. Decker RS, Wildenthal K: Sequential lysosomal alterations during cardiac ischemia II ultrastructural and cytochemical changes. Lab Invest 38: 662-673, 1978
34. Frolov VA, Kapustin UA: Effect of Vit-A and E on the contractile function of the heart in experimental myocardial infarction. Kardiologiia 23: 93-95, 1983
35. Nirmala C, Puranakrishnan R: Effect of curcumin on certain lysosomal hydrolases in isoproterenol induced myocardial infarction in rats. Biochem Pharmacol 51: 47-51, 1996
36. Kennett FF, Weglicki WB: Lack of effect of methyl prednisolone on lysosomal and microsomal enzymes after 2 h of well defined canine myocardial ischemic. Circ Res 43: 759-768, 1987
37. Lass A, Suessenbacher A, Wolkart G, Mayer B, Brunner F: Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol Pharmacol 61: 1081-1088, 2002
38. Rubbo H, Radi R, Trujillo M, Telleri R, Kayanaraman B, Barnes S, Kirk M, Freeman BA: Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269: 26066-26075, 1994
39. 4 induced liver cirrhosis. Protection by Silymarin. Life Sci 48: 1083-1090, 1991
40. Trump BF, Bereezeky IK, Sato T, Liaho KV, Phelps PC, Declaris N: Cell calcium, cell injury and cell death. Environ Health Pers 57: 281-287, 1984
41. Katz AM, Messineo FC: Lipid membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 48: 1-16, 1981
42. Upasani CD, Balaraman R: Effect of vitamin E, Vitamin C and spirulina on the levels of membrane bound enzymes and lipids in some organs of rats exposed to lead. Ind J Pharmacol 33: 185-191, 2001
43. Gubdjorson S, Hallgrimson J, Skuldottir G: In: H. Peter, G.A. Geshaw, R. Paoethi (eds). Arterial Pollution. Properties of Transport Adenosine Triphosphatase. Plenum Publishing Corp., New York, 1983, p 101
44. 450 by nitric oxide and a nitric oxide releasing agent. Arch Biochem Biophys 300: 115-123, 1993
45. Wink DA, Cook JA, Pacelli R, Dehraff W, Gamson J, Liebmann J, Krishna MC, Mitchell JB: The effects of various nitric oxide-donor agents on hydrogen peroxide mediated toxicity: A direct correlation between nitric oxide formation and protection. Arch Biochem Biophy 331: 241-248, 1996
46. Sree Priya M, Devaki T, Nayeem M: Effects of L-arginine on isoproterenol-induced changes in lipid metabolism during experimental myocardial injury in rats. J Clin Biochem Nutr 25: 169-175, 1998
47. Fang H: Mechanisms of nitric-oxide related antimicrobial activity. J Clin Invest 99: 2818-2825, 1997